Site-Specific Prodrug Activation by Antibody-.beta.-Lactamase Conjugates: Preclinical Investigation of the Efficacy and Toxicity of Doxorubicin Delivered by Antibody Directed Catalysis (Q41331887)
scientific article published on July 1, 1995
Language:
(P31) (Q13442814)
(P304) 440-446
(P407) (Q1860)
(P433) 4
(P478) 6
(P577) Saturday, July 1, 1995
(P921) (Q18936)
(Q311379)
(P953) https://pubs.acs.org/doi/pdf/10.1021/bc00034a014
(P1433) (Q2343023)
(P1476) "Site-specific prodrug activation by antibody-beta-lactamase conjugates: preclinical investigation of the efficacy and toxicity of doxorubicin delivered by antibody directed catalysis" (language: en)
"Site-Specific Prodrug Activation by Antibody-.beta.-Lactamase Conjugates: Preclinical Investigation of the Efficacy and Toxicity of Doxorubicin Delivered by Antibody Directed Catalysis" (language: en)
(P2093) D. L. Meyer
K. L. Law
J. K. Payne
S. D. Mikolajczyk
H. Zarrinmayeh
L. N. Jungheim
J. K. Kling
T. A. Shepherd
J. J. Starling
other details
description scientific article published on July 1, 1995

External Links